Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Kosuke, Doki"'
Publikováno v:
Clinical and Translational Science, Vol 15, Iss 3, Pp 771-781 (2022)
Abstract Amiodarone and its main metabolite, desethylamiodarone (DEA), are highly distributed to serum lipoproteins such as very‐low‐density lipoprotein (VLDL) and low‐density lipoprotein (LDL), which are the carriers of triglyceride and choles
Externí odkaz:
https://doaj.org/article/71a5ebee272046b5b5ba2dba3473efc9
Autor:
Takahiro Higashibata, Jun Hamano, Takaomi Kessoku, Shinya Kajiura, Mami Hirakawa, Yoshiki Horie, Masaki Shimizu, Shunsuke Oyamada, Keisuke Ariyoshi, Kota Kihara, Yohei Yamanaka, Kumi Konishi, Kosuke Doki, Yasuyuki Takashima, Manabu Horiuchi, Masato Homma, Takeshi Yamada, Yoshiyuki Yamamoto, Toshikazu Moriwaki, Tatsuya Morita, Atsushi Nakajima, Hiroka Nagaoka
Publikováno v:
Contemporary Clinical Trials Communications, Vol 29, Iss , Pp 100967- (2022)
Background: It is unclear which laxatives are appropriate to prevent opioid-induced constipation (OIC). This study will evaluate whether prophylactic use of naldemedine prevents OIC in patients with cancer who start opioid administration. Methods: Th
Externí odkaz:
https://doaj.org/article/2c8bc9ec4bb74ae79dd65110a614344a
Autor:
Yuki Okada, Daisuke Hitaka, Takahiro Kido, Yu Kanai, Kumi Konishi, Kosuke Doki, Nobuko Katayama, Masato Homma, Yayoi Miyazono, Hidetoshi Takada
Publikováno v:
Case Reports in Pediatrics, Vol 2020 (2020)
Tamoxifen, an estrogen receptor antagonist, is contraindicated in pregnant women due to its teratogenic activity. In the present study, we report the case of an infant whose mother received tamoxifen for breast cancer while unaware of the pregnancy.
Externí odkaz:
https://doaj.org/article/b05de5d3576c4bab834239e679eaa2a1
Publikováno v:
Clinical and Translational Science. 15:771-781
Amiodarone and its main metabolite, desethylamiodarone, are highly distributed to serum lipoproteins such as very-low-density lipoprotein (VLDL) and low-density lipoprotein (LDL), which are the carriers of triglyceride and cholesterol. This study aim
Autor:
Takuya Kaneko, Kosuke Doki, Takeshi Yamada, Yoshiyuki Yamamoto, Toshikazu Moriwaki, Yoshiharu Suzuki, Masato Homma
Publikováno v:
Cancer chemotherapy and pharmacology. 90(5)
Therapeutic monoclonal antibodies, including ramucirumab and nivolumab, are used to treat advanced gastric cancer (AGC). Malignant ascites is often accompanied by peritoneal metastasis in AGC patients. However, the distribution of therapeutic monoclo
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 47:145-149
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 47:33-37
Autor:
Yukinao Kohda, Masato Homma, Masaki Ieda, Yuki Shirayama, Yukio Sekiguchi, Kazutaka Aonuma, Kosuke Doki
Publikováno v:
Pharmacogenomics. 21:1279-1288
Aim: The study aims to investigate the clinical implication of nonfunctional poor metabolizer (PM) alleles and intermediate metabolizer (IM) alleles of CYP2D6, including the CYP2D6*10 allele which shows substrate-dependent decrease in enzymatic activ
Publikováno v:
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 51:331-344
Publikováno v:
Therapeutic Drug Monitoring. 42:554-558
Therapeutic drug monitoring (TDM) and dose adjustment of lenvatinib may be beneficial in the treatment of radioiodine-refractory thyroid cancer, by maximizing antitumor effects and minimizing adverse drug reactions. The aim of this study was, therefo